The Firstt Trial: Assessing Outcomes of Minimally Invasive Leiomyoma Therapies

Researcher

Elizabeth (Ebbie) A. Stewart, M.D.

Summary

Conduct a randomized clinical trial treating 220 women with symptomatic uterine leiomyomas with AUE or MRgFUS and follow them for three years to: report comprehensive outcomes and predictors of outcome; quantitate and compare the ovarian impairment; and produce an economic analysis of UAE and MRgFUS treatment from a U.S. societal perspective